IOVANCE BIOTHERAPEUTICS, INC. Preferred Stock, Shares Outstanding
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Preferred Stock, Shares Outstanding of 1.69 thousand shares as of 2016-03-31, per its 10-Q filed 2016-05-09.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2016-05-09
- 2016-03-31: Preferred Stock, Shares Outstanding 1.69K shares.
- 2015-12-31: Preferred Stock, Shares Outstanding 1.69K shares.
- 2015-09-30: Preferred Stock, Shares Outstanding 3.69K shares.
- 2015-06-30: Preferred Stock, Shares Outstanding 3.69K shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2016-03-31 | 1.69K shares 10-Q · filed 2016-05-09 |
| 2015-12-31 | 1.69K shares 10-Q · filed 2016-05-09 |
| 2015-09-30 | 3.69K shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 3.69K shares 10-Q · filed 2015-08-10 |
| 2015-03-31 | 3.69K shares 10-Q · filed 2015-05-11 |
| 2014-12-31 | 5.69K shares 10-K · filed 2016-03-11 |
| 2014-09-30 | 5.69K shares 10-Q · filed 2014-11-13 |
| 2014-06-30 | 5.80K shares 10-Q · filed 2014-08-08 |
| 2014-03-31 | 13.30K shares 10-Q · filed 2014-05-14 |
| 2013-12-31 | 17.00K shares 10-K · filed 2015-03-16 |
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-14 |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |